• Holger K Eltzschig, Parween Abdulla, Edgar Hoffman, Kathryn E Hamilton, Dionne Daniels, Caroline Schönfeld, Michaela Löffler, German Reyes, Michael Duszenko, Jorn Karhausen, Andreas Robinson, Karen A Westerman, Imogen R Coe, and Sean P Colgan.
• Department of Anesthesiology and Intensive Care Medicine, Tübingen University Hospital, Tübingen, Germany.
• J. Exp. Med. 2005 Dec 5; 202 (11): 1493-505.

AbstractExtracellular adenosine (Ado) has been implicated as central signaling molecule during conditions of limited oxygen availability (hypoxia), regulating physiologic outcomes as diverse as vascular leak, leukocyte activation, and accumulation. Presently, the molecular mechanisms that elevate extracellular Ado during hypoxia are unclear. In the present study, we pursued the hypothesis that diminished uptake of Ado effectively enhances extracellular Ado signaling. Initial studies indicated that the half-life of Ado was increased by as much as fivefold after exposure of endothelia to hypoxia. Examination of expressional levels of the equilibrative nucleoside transporter (ENT)1 and ENT2 revealed a transcriptionally dependent decrease in mRNA, protein, and function in endothelia and epithelia. Examination of the ENT1 promoter identified a hypoxia inducible factor 1 (HIF-1)-dependent repression of ENT1 during hypoxia. Using in vitro and in vivo models of Ado signaling, we revealed that decreased Ado uptake promotes vascular barrier and dampens neutrophil tissue accumulation during hypoxia. Moreover, epithelial Hif1alpha mutant animals displayed increased epithelial ENT1 expression. Together, these results identify transcriptional repression of ENT as an innate mechanism to elevate extracellular Ado during hypoxia.

28 keywords...

hide…